BiotechTube
Advaita

Advaita

Ann Arbor, United States· Est.
advaitabio.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $20M

Overview

Advaita Corporation develops and commercializes advanced bioinformatics software designed to interpret complex multi-omics data. The company's core technology is a proprietary 'impact analysis' algorithm that analyzes the position, role, and interactions of genes within pathways, offering superior accuracy over standard gene set enrichment methods. Advaita's software suite, trusted by major research institutions, empowers biologists and bioinformaticians to derive actionable insights from bulk RNA-seq, single-cell, proteomics, and variant data efficiently and cost-effectively.

AI / Machine LearningGenetics & Genomics

Technology Platform

A proprietary bioinformatics platform centered on 'impact analysis' for pathway interpretation, which models gene interactions within biological networks to provide more accurate insights from multi-omics data than standard enrichment methods.

Funding History

1
Total raised:$20M
Series A$20M

Opportunities

Expansion into the rapidly growing single-cell and spatial genomics analysis market, fueled by a $1.7M NIH grant.
Opportunities to deepen penetration into pharmaceutical R&D and diagnostic development teams that require robust, interpretable pathway analysis.
Potential for platform integration or partnerships with major sequencing service providers or cloud infrastructure companies.

Risk Factors

Facing competition from both entrenched commercial suites (e.g., QIAGEN IPA) and widely adopted free tools.
Reliant on the academic and government research funding environment for its core customer base.
Must continuously invest in R&D to keep pace with rapidly evolving omics technologies and data types.

Competitive Landscape

Main competitors include QIAGEN's Ingenuity Pathway Analysis (IPA) as the legacy commercial leader, and numerous free gene set enrichment tools like DAVID and GSEA. Advaita differentiates through its proprietary impact analysis algorithm for higher accuracy, a focus on user experience for life scientists, and a cost-effective licensing model aimed at core facilities and enterprise teams.

More companies in AI / Machine Learning →More companies in United States →